Skip to content

Follicular Flushing Outcomes in Singles Versus Double Lumen Oocyte Retrieval Needles in Poor Responding Patients

Follicular Flushing Outcomes in Singles Versus Double Lumen Oocyte Retrieval Needles in Poor Responding Patients:a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02391155
Acronym
needles(opu)
Enrollment
80
Registered
2015-03-18
Start date
2015-01-31
Completion date
2015-07-31
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

follicular flushing, IVF, poor responders, oocyte retrival

Brief summary

In this study, the investigators aimed to evaluate to the efficacy of the needle type used in follicular flushing in oocyte retrieval in the poorest responders undergoing IVF.

Detailed description

This study will include: 1. women with less than four follicles on the day of hCG administration 2. women between 20-45 age old 3. The value of progesterone on the day of hCG administration will be under 1.5ng/ml

Interventions

PROCEDUREdouble lumen needle in oocyte retrieval

after aspiration of follicles, 3 times flushing will be performed in double lumen needle.

PROCEDUREsingle lumen needle in oocyte retrieval

single lumen needle use during oocyte retrieval

Sponsors

Baskent University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. women between 20-45 years old 2. the number of follicles less than 5 on the day of HCG administration 3. the value of progesteron on the day of hCG administration must be under 1.5ng/ml

Exclusion criteria

1. women under 20 years and older than 45 year 2. on the day of hCG administration if the follicle number is more than 5 3. if.the value of progesteron on the day of hCG administration is higher than 1.5ng/ml

Design outcomes

Primary

MeasureTime frame
number of metaphase 2 oocyteSix months

Secondary

MeasureTime frame
clinical pregnancy rateeigth months

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026